Search

Your search keyword '"Elles Konijnenberg"' showing total 27 results
Start Over Author "Elles Konijnenberg" Topic psychiatry and mental health
27 results on '"Elles Konijnenberg"'

1. Testing causality in the association between amyloid‐β and tau in genetically identical twins

Author

Emma M Coomans, Jori Tomassen, Rik Ossenkoppele, Elles Konijnenberg, Roos M. Rikken, Lyduine E. Collij, Sandeep SV Golla, Albert D. Windhorst, Betty M. Tijms, Frederik Barkhof, Philip Scheltens, Eco J.C. de Geus, Pieter Jelle Visser, Bart NM van Berckel, and Anouk den Braber

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2022

2. Abnormal cerebrospinal fluid levels of amyloid and tau are associated with cognitive decline over time in cognitively normal older adults: A monozygotic twin study

Author

Jori Tomassen, Anouk den Braber, Sophie M. van der Landen, Elles Konijnenberg, Charlotte E. Teunissen, Lisa Vermunt, Eco J. C. de Geus, Dorret I. Boomsma, Philip Scheltens, Betty M. Tijms, Pieter Jelle Visser, Psychology 6, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Psychiatrie & Neuropsychologie, Biological Psychology, AMS - Sports, AMS - Ageing & Vitality, APH - Personalized Medicine, APH - Mental Health, Amsterdam Reproduction & Development, APH - Methodology, Neurology, Amsterdam Neuroscience - Neurodegeneration, Clinical chemistry, Amsterdam Neuroscience - Neuroinfection & -inflammation, Epidemiology and Data Science, and Amsterdam Neuroscience - Brain Imaging

Subjects
cognition, longitudinal design, SEMANTIC MEMORY, HERITABILITY, preclinical Alzheimer's disease, DEMENTIA, BIOMARKERS, neuropsychology, MEMORY PERFORMANCE, BETA, IMPAIRMENT, cognitive decline, amyloid-beta, cerebrospinal fluid, Psychiatry and Mental health, PATHOLOGY, monozygotic twins, EARLY ALZHEIMERS-DISEASE, Neurology (clinical), tau, PICTURE
Abstract

IntroductionThe contribution of genetic and environmental factors to the relation between cerebrospinal fluid (CSF) biomarkers and cognitive decline in preclinical Alzheimer's disease remains unclear. We studied this in initially cognitively normal monozygotic twins.MethodsWe included 122 cognitively normal monozygotic twins (51 pairs) with a follow-up of 4.3 ± 0.4 years. We first tested associations of baseline CSF Aβ1-42/1-40 ratio, total tau (t-tau), and 181-phosphorylated-tau (p-tau) status with subsequent cognitive decline using linear mixed models, and then performed twin specific analyses.ResultsBaseline abnormal amyloid-β and tau CSF markers predicted steeper decline on memory (p ≤ .003) and language (p ≤ 0.04). Amyloid-β and p-tau markers in one twin predicted decline in memory in the co-twin and tau markers in one twin predicted decline in language in the co-twin (r range -0.26,0.39; p’s ≤ .02).DiscussionThese results suggest that memory and language decline are early features of AD that are in part determined by the same genetic factors that influence amyloid-β and tau regulation.

Published
2022

3. White matter microstructure disruption in early stage amyloid pathology

Author

Herwin Top, Anouk den Braber, Isadora Lopes Alves, Elles Konijnenberg, Mara ten Kate, Dennis van 't Ent, Philip Scheltens, Carole H. Sudre, Kristine Stickney, Viktor Wottschel, Frederik Barkhof, Alle Meije Wink, Lyduine Collij, Pieter Jelle Visser, Jori Tomassen, Maqsood Yaqub, Bart N.M. van Berckel, Silvia Ingala, Radiology and nuclear medicine, Amsterdam Neuroscience - Brain Imaging, VU University medical center, Neurology, Amsterdam Neuroscience - Neurodegeneration, Amsterdam Neuroscience - Neuroinfection & -inflammation, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Psychiatrie & Neuropsychologie, and Biological Psychology

Subjects
Pathology, medicine.medical_specialty, preclinical Alzheimer&apos, magnetic resonance imaging (MRI), preclinical Alzheimer's disease (AD), Amyloid beta, preclinical Alzheimer's disease, Precuneus, Neuroimaging, s disease (AD), Corpus callosum, diffusion tensor imaging (DTI), ), White matter, 03 medical and health sciences, 0302 clinical medicine, POSITRON-EMISSION-TOMOGRAPHY, Fractional anisotropy, mental disorders, medicine, Amyloid beta (Aβ), positron emission tomography (PET), DEPOSITION, RC346-429, 030304 developmental biology, RISK, 0303 health sciences, biology, medicine.diagnostic_test, business.industry, RC952-954.6, Magnetic resonance imaging, REGIONS, Cortex (botany), ALZHEIMERS-DISEASE, MODEL, Psychiatry and Mental health, medicine.anatomical_structure, Amyloid beta (A&#946, Positron emission tomography, Geriatrics, white matter microstructure, biology.protein, Neurology (clinical), Neurology. Diseases of the nervous system, business, 030217 neurology & neurosurgery, Research Article
Abstract

Introduction Amyloid beta (Aβ) accumulation is the first pathological hallmark of Alzheimer's disease (AD), and it is associated with altered white matter (WM) microstructure. We aimed to investigate this relationship at a regional level in a cognitively unimpaired cohort. Methods We included 179 individuals from the European Medical Information Framework for AD (EMIF‐AD) preclinAD study, who underwent diffusion magnetic resonance (MR) to determine tract‐level fractional anisotropy (FA); mean, radial, and axial diffusivity (MD/RD/AxD); and dynamic [18F]flutemetamol) positron emission tomography (PET) imaging to assess amyloid burden. Results Regression analyses showed a non‐linear relationship between regional amyloid burden and WM microstructure. Low amyloid burden was associated with increased FA and decreased MD/RD/AxD, followed by decreased FA and increased MD/RD/AxD upon higher amyloid burden. The strongest association was observed between amyloid burden in the precuneus and body of the corpus callosum (CC) FA and diffusivity (MD/RD) measures. In addition, amyloid burden in the anterior cingulate cortex strongly related to AxD and RD measures in the genu CC. Discussion Early amyloid deposition is associated with changes in WM microstructure. The non‐linear relationship might reflect multiple stages of axonal damage. &nbsp

Published
2021

4. Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease

Author

Elles Konijnenberg, Frederik Barkhof, Jurre den Haan, Bart N.M. van Berckel, Anouk den Braber, Jacoba A. van de Kreeke, Femke H. Bouwman, Mara ten Kate, Charlotte E. Teunissen, Philip Scheltens, Pieter Jelle Visser, Frank D. Verbraak, Neurology, Amsterdam Neuroscience - Neurodegeneration, Ophthalmology, Radiology and nuclear medicine, Clinical chemistry, Psychiatrie & Neuropsychologie, and RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience

Subjects
medicine.medical_specialty, Late onset, lcsh:Geriatrics, lcsh:RC346-429, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Optical coherence tomography, Neuroimaging, Parietal cortical atrophy, Ophthalmology, Cortical atrophy, medicine, Neurodegeneration, lcsh:Neurology. Diseases of the nervous system, 030304 developmental biology, 0303 health sciences, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, Retinal, Biomarker, Alzheimer's disease, medicine.disease, Psychiatry and Mental health, lcsh:RC952-954.6, chemistry, Biomarker (medicine), Neurology (clinical), Erratum, business, Retinal thickness, 030217 neurology & neurosurgery
Abstract

Introduction: Retinal thickness measured with optical coherence tomography has been proposed as a noninvasive biomarker for Alzheimer's disease (AD). We therefore measured retinal thickness in well-characterized AD and control participants, considering ophthalmological confounders.Methods: We included 57 amyloid-proven AD cases and 85 cognitively normal, amyloid-negative controls. All subjects underwent retinal thickness measurements with spectral domain optical coherence tomography and an ophthalmological assessment to exclude ocular disease.Results: Retinal thickness did not discriminate cases from controls, including stratified analyses for early- versus late-onset AD. We found significant associations between macular thickness and global cortical atrophy [β -0.358; P = .01] and parietal cortical atrophy on magnetic resonance imaging [β -0.371; P < .01] in AD cases.Discussion: In this study, representing the largest optical coherence tomography cohort with amyloid-proven AD cases, we show that retinal thickness does not discriminate AD from controls, despite evident changes on clinical, neuroimaging, and CSF measures, querying the use of retinal thickness measurements as an AD biomarker.

Published
2019

5. Early-Onset Dementia Frequency, Diagnostic Procedures, and Quality Indicators in Three European Tertiary Referral Centers

Author

Elles Konijnenberg, Mara ten Kate, Maria Eriksdotter, Seyed-Mohammad Fereshtehnejad, Philip Scheltens, Peter Johannsen, Pieter Jelle Visser, Gunhild Waldemar, Neurology, Amsterdam Neuroscience - Neurodegeneration, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, and Psychiatrie & Neuropsychologie

Subjects
Male, Pediatrics, medicine.medical_specialty, Referral, diagnostic procedures, MEDLINE, Neuropsychological Tests, early-onset dementia, RECOMMENDATIONS, Danish, 03 medical and health sciences, CLINICAL-USE, 0302 clinical medicine, SOCIOECONOMIC INEQUALITIES, Alzheimer Disease, medicine, Dementia, Humans, CRITERIA, Sampling (medicine), Medical prescription, Referral and Consultation, Quality Indicators, Health Care, 030214 geriatrics, business.industry, quality indicators, Middle Aged, CARE, medicine.disease, language.human_language, PREVALENCE, Europe, ALZHEIMERS-DISEASE, Psychiatry and Mental health, Clinical Psychology, Cohort, language, Female, Cholinesterase Inhibitors, HEALTH, Geriatrics and Gerontology, Alzheimer's disease, business, CONSENSUS, Gerontology, EUROPEAN COUNTRIES, 030217 neurology & neurosurgery
Abstract

Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.Methods: We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ("SveDem", Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU University Medical Center).Results: The frequency of EOD among all dementia patients was significantly lower in Copenhagen (410, 20%) and Stockholm (284, 21%) compared with Amsterdam (631, 48%). Not all quality indicator targets were met, such as the time to diagnosis, the mini-mental state examination score available, and the prescription of cholinesterase inhibitors. Cerebrospinal fluid sampling, registered in 2 sites, was performed in over 80% of the subjects.Conclusions: In tertiary referral centers in Copenhagen, Stockholm, and Amsterdam, quality indicators were not always met for patients with EOD. Results partly reflect differences in referral pattern, the application of diagnostic criteria, and local best practices. Standardized international procedures for patients with EOD may reduce this variability.

Published
2017

6. P1‐418: WHITE MATTER MICROSTRUCTURE AND AMYLOID AGGREGATION IN COGNITIVELY HEALTHY, ELDERLY IDENTICAL TWINS

Author

Anouk den Braber, Kristine Stickney, Dennis van 't Ent, Mara ten Kate, Elles Konijnenberg, Jori Tomassen, Frederik Barkhof, Bart N.M. van Berckel, Dorret I. Boomsma, Eco de Geus, Philip Scheltens, and Pieter Jelle Visser

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2018

7. P2‐445: EVENT‐BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β‐AMYLOID DEPOSITION IN THE BRAIN

Author

Bart N.M. Berckel, Frederik Barkhof, Viktor Wottschel, Philip Scheltens, Maqsood Yaqub, Ronald Boellaard, Isadora Lopes Alves, Anouk den Braber, Pieter Jelle Visser, Mark E. Schmidt, Elles Konijnenberg, Fiona Heeman, and Lyduine E. Collij

Subjects
Epidemiology, Chemistry, Health Policy, Event based, 03 medical and health sciences, Psychiatry and Mental health, Cellular and Molecular Neuroscience, 0302 clinical medicine, Developmental Neuroscience, β amyloid, Biophysics, 030212 general & internal medicine, Neurology (clinical), Geriatrics and Gerontology, Deposition (chemistry), 030217 neurology & neurosurgery
Published
2018

8. P1‐525: AMYLOID AGGREGATION IS ASSOCIATED WITH DECLINE ON DIGIT SPAN BACKWARD IN COGNITIVELY NORMAL ELDERLY MONOZYGOTIC TWINS

Author

Anouk den Braber, Sandra D. Mulder, Philip Scheltens, Jori Tomassen, Dorret I. Boomsma, Charlotte E. Teunissen, Mara ten Kate, Elles Konijnenberg, and Pieter Jelle Visser

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Audiology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Amyloid aggregation, Memory span, Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2018

9. P3‐355: ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [ 18 F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI‐QUANTITATIVE AND QUANTITATIVE METHODS

Author

Lyduine Collij, Elles Konijnenberg, Juhan Reimand, Mara ten Kate, Anouk den Braber, Isadora Lopes Alves, Marissa D. Zwan, Maqsood M. Yaqub, Daniëlle van Assema, Alle Meije Wink, Adriaan A. Lammertsma, Philip Scheltens, Pieter Jelle Visser, Frederik Barkhof, and Bart N.M. van Berckel

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2018

10. O2‐09‐05: EXTENSION AND VALIDATION OF AN AMYLOID STAGING MODEL: ASSOCIATIONS WITH CLINICAL MEASURES

Author

Alle Meije Wink, Philip Scheltens, Frederik Barkhof, Pieter Jelle Visser, Mark E. Schmidt, Maqsood Yaqub, Ronald Boellaard, Bart N.M. van Berckel, Anouk den Braber, Lyduine E. Collij, Elles Konijnenberg, Fiona Heeman, and Isadora Lopes Alves

Subjects
Oncology, medicine.medical_specialty, Amyloid, Epidemiology, business.industry, Health Policy, Extension (predicate logic), Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Internal medicine, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2018

11. IC‐P‐005: ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [ 18 F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI‐QUANTITATIVE AND QUANTITATIVE METHODS

Author

Mara ten Kate, Isadora Lopes Alves, Daniëlle M. E. van Assema, Lyduine E. Collij, Elles Konijnenberg, Bart N.M. van Berckel, Anouk den Braber, Frederik Barkhof, Maqsood Yaqub, Pieter Jelle Visser, Adriaan A. Lammertsma, Philip Scheltens, Juhan Reimand, Marissa D. Zwan, and Alle Meije Wink

Subjects
Amyloid pathology, medicine.diagnostic_test, Epidemiology, business.industry, Health Policy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Positron emission tomography, medicine, Neurology (clinical), Geriatrics and Gerontology, business, Nuclear medicine, Semi quantitative
Published
2018

12. IC‐P‐182: EVENT‐BASED MODELING OF THE TEMPORAL ORDERING OF REGIONAL β‐AMYLOID DEPOSITION IN THE BRAIN

Author

Isadora Lopes Alves, Lyduine Collij, Fiona Heeman, Viktor Wottschel, Elles Konijnenberg, Anouk den Braber, Maqsood M. Yaqub, Ronald Boellaard, Pieter Jelle Visser, Bart N.M. van Berckel, Philip Scheltens, Mark E. Schmidt, and Frederik Barkhof

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2018

13. [IC‐P‐065]: WHITE MATTER HYPERINTENSITIES AND VASCULAR RISK FACTORS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Author

Anouk den Braber, Frederik Barkhof, Carole H. Sudre, Mara ten Kate, Elles Konijnenberg, Sebastien Ourselin, Dorret I. Boomsma, M. Jorge Cardoso, Pieter Jelle Visser, and Philip Scheltens

Subjects
Pediatrics, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Monozygotic twin, Healthy elderly, Vascular risk, Hyperintensity, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2017

14. [O2–05–01]: TWIN CORRELATIONS FOR AMYLOID PATHOLOGY MEASURED WITH POSITRON EMISSION TOMOGRAPHY AND IN CEREBROSPINAL FLUID IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Author

Elles Konijnenberg, Anouk Braber, Mara ten Kate, Sofie Adriaanse, Maqsood M. Yaqub, Kees WJ. Uffelen, Charlotte E. Teunissen, Hugo Marcel Vanderstichele, Dorret I. Boomsma, Bart N.M. Berckel, Philip Scheltens, and Pieter Jelle Visser

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2017

15. [P1–404]: EARLY ALTERATIONS IN RESTING‐STATE FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWINS

Author

Anouk Braber, Naomi Prent, Mara ten Kate, Elles Konijnenberg, Frederik Barkhof, Bart N.M. Berckel, Philip Scheltens, Dorret I. Boomsma, and Pieter Jelle Visser

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2017

16. [P1–411]: WHITE MATTER HYPERINTENSITIES AND VASCULAR RISK FACTORS IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Author

Mara ten Kate, Carole H. Sudre, Anouk Braber, Elles Konijnenberg, M. Jorge Cardoso, Philip Scheltens, Sebastien Ourselin, Dorret I. Boomsma, Frederik Barkhof, and Pieter Jelle Visser

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2017

17. [IC‐P‐053]: EARLY ALTERATIONS IN RESTING‐STATE FUNCTIONAL CONNECTIVITY IS ASSOCIATED WITH AMYLOID PATHOLOGY IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWINS

Author

Pieter Jelle Visser, Dorret I. Boomsma, Frederik Barkhof, Philip Scheltens, Bart N.M. van Berckel, Naomi Prent, Anouk den Braber, Mara ten Kate, and Elles Konijnenberg

Subjects
Amyloid pathology, Resting state fMRI, Epidemiology, business.industry, Health Policy, Functional connectivity, Healthy elderly, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Neuroscience
Published
2017

19. [IC‐P‐058]: TWIN CORRELATIONS FOR AMYLOID PATHOLOGY MEASURED WITH POSITRON EMISSION TOMOGRAPHY AND IN CEREBROSPINAL FLUID IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Author

Charlotte E. Teunissen, Philip Scheltens, Elles Konijnenberg, Sofie Adriaanse, Mara ten Kate, Kees W.J. van Uffelen, Dorret I. Boomsma, Bart N.M. van Berckel, Anouk den Braber, Pieter Jelle Visser, Hugo Vanderstichele, and Maqsood Yaqub

Subjects
Pathology, medicine.medical_specialty, Amyloid pathology, medicine.diagnostic_test, Epidemiology, business.industry, Health Policy, Monozygotic twin, Healthy elderly, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Cerebrospinal fluid, Developmental Neuroscience, Positron emission tomography, Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2017

20. [P2–399]: CORRELATION OF GREY MATTER NETWORK MEASURES IN COGNITIVELY HEALTHY ELDERLY MONOZYGOTIC TWIN PAIRS

Author

Elles Konijnenberg, Philip Scheltens, Frederik Barkhof, Pieter Jelle Visser, Mara ten Kate, Anouk den Braber, Dorret I. Boomsma, and Betty M. Tijms

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Monozygotic twin, Healthy elderly, Grey matter, Audiology, Correlation, Psychiatry and Mental health, Cellular and Molecular Neuroscience, medicine.anatomical_structure, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2017

21. P4‐146: Large‐Vessel Disease and [18F]Flutemetamol‐Amyloid Deposition in Cognitively Healthy Elderly Twins

Author

Elles Konijnenberg, Erik H. Serné, Pieter Jelle Visser, Lisa Vermunt, Mara ten Kate, Philip Scheltens, Dorret I. Boomsma, Bart N.M. van Berckel, Anouk den Braber, and Maqsood Yaqub

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Large vessel, Disease, Healthy elderly, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Amyloid deposition, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2016

23. IC‐P‐017: Concordance of [18F]Flutemetamol Amyloid Deposition in Cognitively Healthy Elderly Monozygotic Twin Pairs

Author

Elles Konijnenberg, Sofie Adriaanse, Mara ten Kate, Maqsood Yaqub, Philip Scheltens, Bart N.M. van Berckel, Anouk den Braber, Dorret I. Boomsma, and Pieter Jelle Visser

Subjects
Genetics, Pediatrics, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Concordance, Monozygotic twin, Healthy elderly, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Amyloid deposition, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2016

25. IC‐02‐04: Correlation of Cortical Thickness in Cognitively Healthy Elderly Monozygotic Twin Pairs

Author

Philip Scheltens, Frederik Barkhof, Betty M. Tijms, Anouk den Braber, Pieter Jelle Visser, Mara ten Kate, Dorret I. Boomsma, and Elles Konijnenberg

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Monozygotic twin, Healthy elderly, Audiology, Correlation, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2016

26. O3‐11‐02: Prevalence and diagnostic procedures in early‐onset dementia in tertiary referral center patients in denmark, sweden, and the netherlands

Author

Elles Konijnenberg, Philip Scheltens, Peter Johannsen, Seyed-Mohammad Fereshtehnejad, Gunhild Waldemar, Maria Eriksdotter, and Pieter Jelle Visser

Subjects
Pediatrics, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Referral center, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Early onset dementia
Published
2015

27. O5‐02‐04: VASCULAR AND CLINICAL CORRELATES OF MICROBLEEDS IN PRODROMAL AD

Author

Philip Scheltens, Thomas Hartmann, Pieter Jelle Visser, Johannes Schröder, Yiona Lam, Hilkka Soininen, Elles Konijnenberg, and Daniela Bertens

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2014

Catalog

Books, media, physical & digital resources
See catalog results